Cho, Iksung

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Keech, C., Albert, G., Cho, I., Robertson, A., Reed, P., Neal, S., Plested, J. S., Zhu, M., Cloney-Clark, S., Zhou, H., et al. (2020) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,156

Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant

Shinde, V., Bhikha, S., Hoosain, Z., Archary, M., Bhorat, Q., Fairlie, L., Lalloo, U., Masilela, M. S. L., Moodley, D., Hanley, S., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 625

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Shinde, V., Bhikha, S., Hoosain, Z., Archary, M., Bhorat, Q., Fairlie, L., Lalloo, U., Masilela, M. S. L., Moodley, D., Hanley, S., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 625

Evaluation of a SARS-CoV-2 Vaccine NVX-CoV2373 in Younger and Older Adults

Formica, N., Mallory, R., Albert, G., Robinson, M., Plested, J. S., Cho, I., Robertson, A., Dubovsky, F., Glenn, G. M., & for the 2019nCoV-101 Study Group (2021) · PLoS Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 111

Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants

Lee, M., Greenberg, D. P., Yeh, S. H., Yogev, R., Reisinger, K. S., Ward, J. I., Blatter, M. M., Cho, I., Holmes, S. J., Cordova, J. M., et al. (2001) · The Journal of Infectious Diseases

Respiratory viral infections researchVirology and Viral Diseases

Cited by 37